National Comprehensive Cancer Network



Educational Events & Programs

NCCN 17th Annual Conference:
Clinical Practice Guidelines & Quality Cancer Care™

2012 NCCN Pharmacy Program: Best Practices in Oncology Pharmacy Management™

Wednesday, March 14, 2012
1:00 – 6:00 PM

The Westin Diplomat
Hollywood, Florida

Register Now!


Program Overview:
This half-day program is a unique, educational event designed to provide pharmacists with information on integral topics as they apply to the pharmacy role in quality cancer care. The program is a series of presentations aimed at addressing issues faced by oncology pharmacists in various settings. Speakers are comprised of faculty who are recognized leaders in oncology across the United States.

Please join us for the NCCN Fellows, Nurses, and Pharmacists Reception in the Registration Foyer, Great Hall Level from 6:00 – 8:00 PM on Tuesday, March 13, 2012. This reception is sponsored by Eisai Inc.

Agenda*:

1:00 – 1:05 PM
Welcome
Jake B. Guinto, PhD
Manager, Oncology Drugs & Biologics
National Comprehensive Cancer Network

1:05 – 2:35 PM
Supportive Care in Oncology Pharmacy
Sally Yowell Barbour, PharmD, BCOP, CPP
Director of Oncology Pharmacy Programs, Department of Pharmacy
Duke University Medical Center

Ashley Morris Engemann, PharmD, BCOP
Clinical Associate, Division of Cellular Therapy
Duke Cancer Institute

Susan Urba, MD
Professor of Internal Medicine, Division of Hematology/Oncology
Medical Director, Symptom Management & Supportive Care Program
University of Michigan Comprehensive Cancer Center

2:40 – 3:40 PM
New and Emerging Drugs and Biologics in Cancer Care
Van Anh Trinh, PharmD, BCOP
Clinical Pharmacy Specialist, Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Robert Ignoffo, PharmD, FASHP, FCSHP
Clinical Professor Emeritus
University of California-San Francisco
Professor of Pharmacy
College of Pharmacy, Touro University

3:40 – 3:55 PM
Break

4:00 – 4:45 PM
Oral Chemotherapy and Compliance

Sylvia Bartel, RPh
Vice President of Pharmacy
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center

4:50 – 5:50 PM
Case Study: Pharmacy Interventions that Improve Quality of Care

Audrea H. Szabatura, PharmD, BCOP
Oncology Medication Safety Officer, Department of Pharmacy
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General
Hospital Cancer Center

5:50 – 6:00 PM
Closing Remarks

Jake B. Guinto, PhD
Manager, Oncology Drugs & Biologics
National Comprehensive Cancer Network

*This agenda is tentative and subject to change.

Accreditation

Pharmacists Continuing Education

Pharmacy Educational Objective:
After completing this activity, the participant should be able to provide accurate and appropriate counsel as part of the treatment team.

National Comprehensive Cancer Network is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Credit Designation Statement

National Comprehensive Cancer Network designates this continuing education activity for a maximum of 4.25 contact hour(s) (0.425 CEUs) of continuing education credit in states that recognize ACPE accredited providers.

Type of Activity
Knowledge

Supportive Care in Oncology Pharmacy:
National Comprehensive Cancer Network designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of continuing education credit in states that recognize ACPE accredited providers. Universal Activity Number: 0836-0000-12-001-L01-P

New and Emerging Drugs and Biologics in Cancer Care:
National Comprehensive Cancer Network designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of continuing education credit in states that recognize ACPE accredited providers. Universal Activity Number: 0836-0000-12-002-L01-P

Oral Chemotherapy and Compliance:
National Comprehensive Cancer Network designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of continuing education credit in states that recognize ACPE accredited providers. Universal Activity Number: 0836-0000-12-003-L01-P

Case Study: Pharmacy Interventions that Improve Quality of Care:
National Comprehensive Cancer Network designates this continuing education activity for 1.0 contact hour(s) (0.1CEUs) of continuing education credit in states that recognize ACPE accredited providers. Universal Activity Number: 0836-0000-12-004-L01-P

Pharmacists must be present for the March 14th Pharmacy Program to qualify for complimentary registration to the NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™. Pharmacists not in attendance during the actual Pharmacy Program who are onsite will be charged the full registration fee and the regular hotel rates.


Register now for the 2012 NCCN Pharmacy Program:
Best Practices in Oncology Pharmacy Management™